Lipid Nanoparticles white paper updated thumbnail

Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles were propelled into the global spotlight for their role in two approved COVID mRNA vaccines. However, lipid nanoparticles aren't unique, in fact their development started decades ago as liposomes and as critical drug delivery vehicles. Only now, has more and more opportunities for advancement and applications emerged.

Lipid Nanoparticles white paper cover

{{lipid="/ads"}}

Download the CAS Insights Report

Related CAS Insights

Aspectos destacados del seminario web de CAS Insights sobre el panorama de las patentes farmacéuticas

La nueva investigación traslacional en inmuno-oncología podría llegar a pacientes que no responden a las terapias actuales

Informe de CAS Insights: Desbloqueando el futuro de la innovación farmacéutica a través de la inteligencia de patentes.

Gain new perspectives for faster progress directly to your inbox.